5.6(top 2%)
Impact Factor
6.3(top 2%)
extended IF
150(top 2%)
H-Index
4.5K
authors
12.5K
papers
324.7K
citations
8K
citing journals
63.9K
citing authors

Most Cited Articles of BJU International

TitleYearCitations
How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study20011.2K
The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences1999771
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction2011596
The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study2008580
The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing1996502
The prevalence of urinary incontinence in women in four European countries2004488
Robotically-assisted laparoscopic radical prostatectomy2001473
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study2009467
Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial1998462
Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion2003461
A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution2003449
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system2013427
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial2003406
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer2008402
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus2004387
Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function1999374
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome2005350
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group2012330
Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder1998330
Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis2000325
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder2004314
Anatomical studies of the neurovascular bundle and cavernosal nerves2004307
Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection2011305
Scarless single port transumbilical nephrectomy and pyeloplasty: first clinical report2008303
Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis1997300